|Title:||The role of policies and networks in development of cord blood usage in China||Authors:||HUNG-CHIEH CHANG||Keywords:||bionetworking; China; cord blood; cord blood banking; network; policy; stem cell||Issue Date:||Sep-2017||Journal Volume:||12||Journal Issue:||6||Start page/Pages:||637-645||Source:||Regenerative medicine||Abstract:||
Research regarding the use of cord blood (CB) has focused on antigen match and the number of stem cells, with policies and networks related to its use being under researched. This article is based on fieldwork in China from 2013 to 2015 and examines ways that the studied CB bank enhances CB usage in China. This article identifies that in addition to finding a match, CB use is linked to the policies and networks, release fee and public awareness that enable CB usage development. ? 2017 Future Medicine Ltd.
|DOI:||10.2217/rme-2017-0050||metadata.dc.subject.other:||HLA antigen; biotechnology; blood bank; blood group typing; China; cord blood stem cell transplantation; health care access; health care cost; health care policy; health care utilization; human; licensing; marketing; mass medium; priority journal; Review; umbilical cord blood; China; cytology; ethics; fetus blood; legislation and jurisprudence; transplantation; trends; Blood Banks; China; Cord Blood Stem Cell Transplantation; Fetal Blood
|Appears in Collections:||健康政策與管理研究所|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.